Device data
Health topic Child mortality
Classification Treatment
Scope Clinical trial
Manufacturer
location
North Carolina, United States

Neonatal jaundice, also known as hyperbilirubinemia, is a shockingly common condition that occurs when infants' livers are not fully developed. Low-resource settings often do not have the necessary devices to treat infants with neonatal jaundice because traditional phototherapy devices are too expensive for the developing world. They are also impractical due to frequent power outages.

Detailed description of the solution

BluLine Phototherapy uses LED technology to treat neonatal jaundice. The device includes a long lasting light blub and can be powered by a car or motorcycle battery. The LED technology consumes much less power than fluorescent tubes, and the battery offers 24 hours of power supply. Approximately the size of a boomerang, BluLine Phototherapy is also very portable.

Designed by

When and where it was tested/implemented

Being field tested in Honduras, Tanzania, and Nicaragua

References

Other internally generated reports

Photogensis Medical. (2008). Retrieved November 20 2013 from here.

Externally generated reports

Maternova. (January 11 2013). BluLine Phototherapy. Retrieved November 20 2013 from here.

Page data
SDG SDG03 Good health and well-being, SDG09 Industry innovation and infrastructure
Authors Lonny Grafman, Chris Waterguy, Emilio, Kathleen Sienko, Amir Sabet Sarvestani
License CC-BY-SA-3.0
Organizations Appropedia Foundation, University of Michigan
Language English (en)
Related 0 subpages, 1 pages link here
Redirects BluLine Phototherapy
Views 63 page views (analytics)
Created November 20, 2013 by Kelly Wojcik
Last edit September 10, 2026 by Felipe Schenone